Critical Review: Grown Rogue International (OTCMKTS:GRUSF) vs. Yield10 Bioscience (NASDAQ:YTEN)

Grown Rogue International (OTCMKTS:GRUSF) and Yield10 Bioscience (NASDAQ:YTEN) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, dividends, earnings, profitability, analyst recommendations, valuation and risk.

Profitability

This table compares Grown Rogue International and Yield10 Bioscience’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Grown Rogue International	-1.70%	-3.71%	-1.67%
Yield10 Bioscience	N/A	-888.81%	-273.34%

Analyst Recommendations

This is a summary of current ratings and recommmendations for Grown Rogue International and Yield10 Bioscience, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Grown Rogue International	0	0	0	0	N/A
Yield10 Bioscience	0	2	1	0	2.33

Yield10 Bioscience has a consensus price target of $3.50, indicating a potential upside of 1,478.00%. Given Yield10 Bioscience’s higher probable upside, analysts clearly believe Yield10 Bioscience is more favorable than Grown Rogue International.

Earnings and Valuation

This table compares Grown Rogue International and Yield10 Bioscience’s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Grown Rogue International	$23.35 million	6.16	-$130,000.00	$0.01	72.44
Yield10 Bioscience	$60,000.00	56.93	-$14.45 million	($2.08)	-0.11

Grown Rogue International has higher revenue and earnings than Yield10 Bioscience. Yield10 Bioscience is trading at a lower price-to-earnings ratio than Grown Rogue International, indicating that it is currently the more affordable of the two stocks.

Institutional and Insider Ownership

9.3% of Grown Rogue International shares are owned by institutional investors. Comparatively, 4.9% of Yield10 Bioscience shares are owned by institutional investors. 23.2% of Grown Rogue International shares are owned by company insiders. Comparatively, 6.1% of Yield10 Bioscience shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Volatility & Risk

Grown Rogue International has a beta of 0.79, meaning that its share price is 21% less volatile than the S&P 500. Comparatively, Yield10 Bioscience has a beta of 1.58, meaning that its share price is 58% more volatile than the S&P 500.

Summary

Grown Rogue International beats Yield10 Bioscience on 8 of the 13 factors compared between the two stocks.

About Grown Rogue International

Grown Rogue International Inc., together with its subsidiaries, produces and sells cannabis products in the United States. It offers a range of cultivars for consumers, which are classified as indicas, sativas, and hybrids, as well as provides consulting services. The company sells its products through dispensaries. Grown Rogue International Inc. is headquartered in Medford, Oregon.

About Yield10 Bioscience

Yield10 Bioscience, Inc. operates as agricultural bioscience company in the United States. The company primarily focus on production of low carbon products through processing Camelina seeds. Its products include Camelina oil for low carbon biofuel feedstock; Omega-3 oils for nutrition; and PHA bioplastics for biodegradable zero waste packaging solutions. The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was incorporated in 1992 and is headquartered in Woburn, Massachusetts.